Insulet announces the commercial launch of Omnipod 5 AID system in Canada, with Dexcom G6 and G7 CGM sensor compatibility.

Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in ...

Dexcom advanced the launch of Stelo, its over-the-counter product for non-insulin type 2 diabetes, pre-diabetes, and ...

Let’s delve deeper. Strong Product Demand: We are upbeat about DexCom's continued strength in CGM products. In the fourth quarter, Dexcom’s G7 system continued its robust momentum. Accelerated ...

O Shaughnessy Asset Management LLC raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 16.9% during the fourth quarter, according to its most recent filing with the SEC. The ...

The government of Saskatchewan has expanded public coverage for continuous glucose monitoring (CGM) systems. The expansion, which now provides full coverage for CGMs for young adults ages 18 to 25 and ...

Mizuho analyst Anthony Petrone initiated coverage of DexCom (DXCM) with an Outperform rating and $85 price target The firm cites its positive ...